CCN2 and hepatocellular carcinoma: In hepatocellular carcinoma, lnc34a was identified to promote bone metastasis acting through suppression of miR-34a, which inhibits TGF-ß/Smad signaling and its downstream targets, connective tissue growth factor (CTGF) and IL-11 [174].